 | Up a level |
Pozdnyakova, O., Rodig, S., Bhandarkar, S., Wu, K., Thiele, J. and Hasserjian, R. (2015). The importance of central pathology review in international trials: a comparison of local versus central bone marrow reticulin grading. Leukemia, 29 (1). S. 241 - 246. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5551
Pozdnyakova, O., Wu, K., Patki, A., Rodig, S. J., Thiele, J. and Hasserjian, R. (2014). High Concordance in Grading Reticulin Fibrosis and Hematopoietic Cellularity in Patients with Myeloproliferative Neoplasms Enrolled on Fedratinib (A JAK2 Inhibitor) Trials. Lab. Invest., 94. S. 371A - 373. NEW YORK: NATURE PUBLISHING GROUP. ISSN 1530-0307
Pozdnyakova, O., Wu, K., Patki, A., Rodig, S. J., Thiele, J. and Hasserjian, R. (2014). High Concordance in Grading Reticulin Fibrosis and Hematopoietic Cellularity in Patients with Myeloproliferative Neoplasms Enrolled on Fedratinib (A JAK2 Inhibitor) Trials. Mod. Pathol., 27. S. 371A - 373. NEW YORK: NATURE PUBLISHING GROUP. ISSN 1530-0285